Mechanism for possible chemopreventive effects of natural dietary compounds on smoking-induced tumorigenesis

Journal of Experimental and Clinical Medicine

Volumn 3, Issue 6, 2011, Pages 262-271

  Lai, Ching Shu ^a   Pan, Min Hsiung ^a  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Chemoprevention; Cigarette smoking; Healthy food; Nicotine; Tumorigenesis

Indexed keywords

APIGENIN; CARCINOGEN; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOL DERIVATIVE; FLAVONOLIGNAN DERIVATIVE; GARCINOL; GENISTEIN; HERBACEOUS AGENT; HESPERIDIN; ISOFLAVONE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; LIMONENE; NATURAL PRODUCT; NICOTINE; NICOTINIC RECEPTOR; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN; QUERCETIN; RESVERATROL; RETINOIC ACID; SILIBININ; SULFORAPHANE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN;

ANGIOGENESIS; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FRUIT; GRAIN; HUMAN; LEGUME; LUNG CANCER; MOUTH CANCER; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKING; TEA; VEGETABLE; WINE;

EID: 83555178438     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2011.10.003     Document Type: Review

References (91)

1. Catassi A., Servent D., Paleari L., Cesario A., Russo P. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 2008, 659:221-231.
2. Chen R.J., Ho Y.S., Wu C.H., Wang Y.J. Molecular mechanisms of nicotine-induced bladder cancer. J Exp Clin Med 2011, 3:252-256.
3. Hung C.S., Pung Y.J., Wei P.L., Lee C.H., Su H.Y., Ho S.Y., Wu C.H., et al. The alpha9 nicotinic acetylcholine receptor is the key mediator in nicotine-enhanced cancer metastasis in breast cancer cells. J Exp Clin Med 2011, 3:283-292.
4. Wei P.L., Lin S.Y., Chang Y.J. Cigarette smoking and colorectal cancer: from epidemiology to bench. J Exp Clin Med 2011, 3:257-261.
5. Crowley-Weber C.L., Dvorakova K., Crowley C., Bernstein H., Bernstein C., Garewal H., Payne C.M. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 2003, 145:53-66.
6. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., Cho C.H. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci 2007, 97:279-287.
7. D'hoedt D., Bertrand D. Nicotinic acetylcholine receptors: an overview on drug discovery. Expert Opin Ther Targets 2009, 13:395-411.
8. Wu C.H., Lee C.H., Ho Y.S. Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin Cancer Res 2011, 17:3533-3541.
9. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., Swain S.M., Harris C., et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003, 111:81-90.
10. Sun X., Ritzenthaler J.D., Zhong X., Zheng Y., Roman J., Han S. Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res 2009, 69:6445-6453.
11. Dasgupta P., Kinkade R., Joshi B., Decook C., Haura E., Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A 2006, 103:6332-6337.
12. Resende R.R., Adhikari A. Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun Signal 2009, 7:20.
13. Jin Z., Gao F., Flagg T., Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem 2004, 279:40209-40219.
14. Ho Y.S., Chen C.H., Wang Y.J., Pestell R.G., Albanese C., Chen R.J., Chang M.C., et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 2005, 205:133-148.
15. Barr J., Sharma C.S., Sarkar S., Wise K., Dong L., Periyakaruppan A., Ramesh G.T. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol Cell Biochem 2007, 297:93-99.
16. Hecht S.S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 1999, 424:127-142.
17. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M., Haura E., Chellappan S. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 2006, 116:2208-2217.
18. Shin V.Y., Wu W.K., Chu K.M., Wong H.P., Lam E.K., Tai E.K., Koo M.W., et al. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res 2005, 3:607-615.
19. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., Luo J.C., Cho C.H. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther 2004, 308:66-72.
20. Dom A.M., Buckley A.W., Brown K.C., Egleton R.D., Marcelo A.J., Proper N.A., Weller D.E., et al. The {alpha}7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells. Invest Ophthalmol Vis Sci 2011, 52:4428-4438.
21. Davis R., Rizwani W., Banerjee S., Kovacs M., Haura E., Coppola D., Chellappan S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 2009, 4:e7524.
22. Dasgupta P., Rizwani W., Pillai S., Kinkade R., Kovacs M., Rastogi S., Banerjee S., et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 2009, 124:36-45.
23. Wei P.L., Kuo L.J., Huang M.T., Ting W.C., Ho Y.S., Wang W., An J., et al. Nicotine enhances colon cancer cell migration by induction of fibronectin. Ann Surg Oncol 2011, 18:1782-1790.
24. Pan M.H., Ho C.T. Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 2008, 37:2558-2574.
25. Pan M.H., Lai C.S., Dushenkov S., Ho C.T. Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 2009, 57:4467-4477.
26. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 2004, 134:3479S-3485S.
27. Jeong G.S., Lee S.H., Jeong S.N., Kim Y.C., Kim E.C. Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. Int Immunopharmacol 2009, 9:1374-1380.
28. Meyer H., Bolarinwa A., Wolfram G., Linseisen J. Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab 2006, 50:167-172.
29. Bear W.L., Teel R.W. Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Anticancer Res 2000, 20:3323-3329.
30. Muthukumaran S., Sudheer A.R., Nalini N., Menon V.P. Effect of quercetin on nicotine-induced biochemical changes and DNA damage in rat peripheral blood lymphocytes. Redox Rep 2008, 13:217-224.
31. Muthukumaran S., Sudheer A.R., Menon V.P., Nalini N. Protective effect of quercetin on nicotine-induced pro-oxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology 2008, 243:207-215.
32. Shih Y.L., Liu H.C., Chen C.S., Hsu C.H., Pan M.H., Chang H.W., Chang C.H., et al. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors. J Agric Food Chem 2010, 58:235-241.
33. Smith A.J., Kavuru P., Wojtas L., Zaworotko M.J., Shytle R.D. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharm 2011, 8:1867-1876.
34. Chen X., Yin O.Q., Zuo Z., Chow M.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 2005, 22:892-901.
35. Sang S., Lambert J.D., Ho C.T., Yang C.S. Green tea polyphenols. Encyclopedia of dietary supplements 2005, Informa Healthcare, New York, pp. 327-336.
36. Liu L., Castonguay A. Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin. Carcinogenesis 1991, 12:1203-1208.
37. Rundlof T., Olsson E., Wiernik A., Back S., Aune M., Johansson L., Wahlberg I. Potential nitrite scavengers as inhibitors of the formation of N-nitrosamines in solution and tobacco matrix systems. J Agric Food Chem 2000, 48:4381-4388.
38. Weitberg A.B., Corvese D. The effect of epigallocatechin galleate and sarcophytol A on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. J Exp Clin Cancer Res 1999, 18:433-437.
39. Chung F.L. The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black tea. Proc Soc Exp Biol Med 1999, 220:244-248.
40. Matsunaga K., Klein T.W., Friedman H., Yamamoto Y. In vitro therapeutic effect of epigallocatechin gallate on nicotine-induced impairment of resistance to Legionella pneumophila infection of established MH-S alveolar macrophages. J Infect Dis 2002, 185:229-236.
41. Tu S.H., Ku C.Y., Ho C.T., Chen C.S., Huang C.S., Lee C.H., Chen L.C., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol Nutr Food Res 2011, 55:455-466.
42. Lambert J.D., Yang C.S. Mechanisms of cancer prevention by tea constituents. J Nutr 2003, 133:3262S-3267S.
43. Chow H.H., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., Dorr R.T., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9:3312-3319.
44. Banerjee S., Manna S., Saha P., Panda C.K., Das S. Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev 2005, 14:215-221.
45. Balakrishnan A., Menon V.P. Effect of hesperidin on matrix metalloproteinases and antioxidant status during nicotine-induced toxicity. Toxicology 2007, 238:90-98.
46. Balakrishnan A., Menon V.P. Antioxidant properties of hesperidin in nicotine-induced lung toxicity. Fundam Clin Pharmacol 2007, 21:535-546.
47. Balakrishnan A., Menon V.P. Protective effect of hesperidin on nicotine induced toxicity in rats. Indian J Exp Biol 2007, 45:194-202.
48. Kohno H., Taima M., Sumida T., Azuma Y., Ogawa H., Tanaka T. Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett 2001, 174:141-150.
49. Kanaze F.I., Bounartzi M.I., Georgarakis M., Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007, 61:472-477.
50. Manach C., Morand C., Gil-Izquierdo A., Bouteloup-Demange C., Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 2003, 57:235-242.
51. Cornwell T., Cohick W., Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004, 65:995-1016.
52. Cattaneo M.G., D'atri F., Vicentini L.M. Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem J 1997, 328(Pt 2):499-503.
53. Charpantier E., Wiesner A., Huh K.H., Ogier R., Hoda J.C., Allaman G., Raggenbass M., et al. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci 2005, 25:9836-9849.
54. Chipitsyna G., Gong Q., Anandanadesan R., Alnajar A., Batra S.K., Wittel U.A., Cullen D.M., et al. Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer 2009, 125:276-285.
55. Rasmussen S.E., Frederiksen H., Struntze K.K., Poulsen L. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res 2005, 49:159-174.
56. Song X., Siriwardhana N., Rathore K., Lin D., Wang H.C. Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Mol Carcinog 2010, 49:450-463.
57. Tota S., Kamat P.K., Shukla R., Nath C. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 2011, 221:207-215.
58. Chung F.L. Dietary isothiocyanates: roles in cancer prevention and metabolism in rodents and humans. Phytochemicals in nutrition and health 2002, 227-245. CRC Press, Boca Raton Fl. M.S. Meskin, BidlackWR, A.J. Davies, S.T. Omaye (Eds.).
59. Conaway C.C., Wang C.X., Pittman B., Yang Y.M., Schwartz J.E., Tian D., McIntee E.J., et al. Phenethyl isothiocyanate and sulforaphane and their Nacetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res 2005, 65:8548-8557.
60. Ding Y., Paonessa J.D., Randall K.L., Argoti D., Chen L., Vouros P., Zhang Y. Sulforaphane inhibits 4-aminobiphenyl-induced DNA damage in bladder cells and tissues. Carcinogenesis 2010, 31:1999-2003.
61. Hanlon N., Coldham N., Gielbert A., Kuhnert N., Sauer M.J., King L.J., Ioannides C. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br J Nutr 2008, 99:559-564.
62. Vermeulen M., Klopping-Ketelaars I.W., van den B.R., Vaes W.H. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J Agric Food Chem 2008, 56:10505-10509.
63. Hecht S.S. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 1999, 129:768S-774S.
64. Ye B., Zhang Y.X., Yang F., Chen H.L., Xia D., Liu M.Q., Lai B.T. Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. BMC Cancer 2007, 7:90.
65. Stoner G.D., Adams C., Kresty L.A., Amin S.G., Desai D., Hecht S.S., Morse M.A., et al. Inhibition of N'-nitrosonornicotine-induced esophageal tumorigenesis by 3-phenylpropyl isothiocyanate. Carcinogenesis 1998, 19:2139-2143.
66. Murphy S.E., Heiblum R., King P.G., Bowman D., Davis W.J., Stoner G.D. Effect of phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral tissue. Carcinogenesis 1991, 12:957-961.
67. Konsue N., Kirkpatrick J., Kuhnert N., King L.J., Ioannides C. Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol Nutr Food Res 2010, 54:426-432.
68. Ji Y., Kuo Y., Morris M.E. Pharmacokinetics of dietary phenethyl isothiocyanate in rats. Pharm Res 2005, 22:1658-1666.
69. Hecht S.S., Kenney P.M., Wang M., Trushin N., Upadhyaya P. Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett 2000, 150:49-56.
70. von Weymarn L.B., Chun J.A., Hollenberg P.F. Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. Carcinogenesis 2006, 27:782-790.
71. Wagner K.H., Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann Nutr Metab 2003, 47:95-106.
72. Morse M.A., Toburen A.L. Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene. Cancer Lett 1996, 104:211-217.
73. Wattenberg L.W., Coccia J.B. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 1991, 12:115-117.
74. Langenfeld J., Lonardo F., Kiyokawa H., Passalaris T., Ahn M.J., Rusch V., et al. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene 1996, 13:1983-1990.
75. Mernitz H., Smith D.E., Zhu A.X., Wang X.D. 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. Cancer Lett 2006, 244:101-108.
76. Lin J.K., Pan M.H., Lin-Shiau S.Y. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 2000, 13:153-158.
77. Pan M.H., Lin-Shiau S.Y., Lin J.K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000, 60:1665-1676.
78. Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., Limtrakul P., et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28:1765-1773.
79. Kalpana C., Menon V.P. Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 2004, 53:82-86.
80. Kalpana C., Menon V.P. Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol 2004, 56:581-586.
81. Cheng Y., Li H.L., Wang H.F., Sun H.F., Liu Y.F., Peng S.X., Liu K.X., et al. Inhibition of nicotine-DNA adduct formation in mice by six dietary constituents. Food Chem Toxicol 2003, 41:1045-1050.
82. Bandyopadhyaya G., Sinha S., Chattopadhyay B.D., Chakraborty A. Protective role of curcumin against nicotine-induced genotoxicity on rat liver under restricted dietary protein. Eur J Pharmacol 2008, 588:151-157.
83. Puliyappadamba V.T., Cheriyan V.T., Thulasidasan A.K., Bava S.V., Vinod B.S., Prabhu P.R., Varghese R., et al. Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer 2010, 9:220.
84. Clark C.A., McEachern M.D., Shah S.H., Rong Y., Rong X., Smelley C.L., Caldito G.C., et al. Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma. Cancer Prev Res (Phila) 2010, 3:1586-1595.
85. Sharma C., Kaur J., Shishodia S., Aggarwal B.B., Ralhan R. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 2006, 228:1-15.
86. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4:807-818.
87. Sgambato A., Ardito R., Faraglia B., Boninsegna A., Wolf F.I., Cittadini A. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 2001, 496:171-180.
88. Revel A., Raanani H., Younglai E., Xu J., Rogers I., Han R., Savouret J.F., et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol 2003, 23:255-261.
89. Wen X., Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 2005, 26:1774-1781.
90. Ito C., Itoigawa M., Takakura T., Ruangrungsi N., Enjo F., Tokuda H., Nishino H., et al. Chemical constituents of Garcinia fusca: structure elucidation of eight new xanthones and their cancer chemopreventive activity. J Nat Prod 2003, 66:200-205.
91. Chen C.S., Lee C.H., Hsieh C.D., Ho C.T., Pan M.H., Huang C.S., Tu S.H., et al. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res Treat 2011, 125:73-87.